This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Penmix Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Young Sub Song - Innovator in Lipolytic Composition
Introduction
Young Sub Song is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of obesity treatment. His innovative work focuses on developing effective solutions for lipolysis, which is the breakdown of fats.
Latest Patents
Young Sub Song holds a patent for a lipolytic composition containing phosphocholine derivatives. This invention provides a pharmaceutical composition aimed at preventing or treating obesity, specifically targeting localized fat deposits. The composition includes certain phosphocholine derivatives or their pharmaceutically acceptable salts. It demonstrates excellent lipolytic activity and uniformity, while also minimizing side effects such as inflammation and tissue necrosis at the administered site. Furthermore, the composition boasts excellent storage stability, making it a promising option in the pharmaceutical market.
Career Highlights
Young Sub Song is associated with Penmix Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and the pursuit of effective treatments for obesity.
Collaborations
Some of his coworkers include Dongkyu Park and Hana Lee, who contribute to the collaborative environment at Penmix Ltd. Their combined expertise enhances the potential for groundbreaking advancements in their field.
Conclusion
Young Sub Song is a pioneering inventor whose work in lipolytic compositions is paving the way for new treatments in obesity management. His contributions are significant and reflect a dedication to improving health outcomes through innovative pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile